KLTO
Price
$0.49
Change
-$0.01 (-2.00%)
Updated
Sep 5 closing price
Capitalization
29.77M
PHAT
Price
$12.34
Change
+$0.34 (+2.83%)
Updated
Sep 5 closing price
Capitalization
875.45M
61 days until earnings call
Interact to see
Advertisement

KLTO vs PHAT

Header iconKLTO vs PHAT Comparison
Open Charts KLTO vs PHATBanner chart's image
Klotho Neurosciences
Price$0.49
Change-$0.01 (-2.00%)
Volume$15.7M
Capitalization29.77M
Phathom Pharmaceuticals
Price$12.34
Change+$0.34 (+2.83%)
Volume$1.21M
Capitalization875.45M
KLTO vs PHAT Comparison Chart in %
Loading...
KLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KLTO vs. PHAT commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KLTO is a Hold and PHAT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (KLTO: $0.49 vs. PHAT: $12.34)
Brand notoriety: KLTO and PHAT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KLTO: 398% vs. PHAT: 113%
Market capitalization -- KLTO: $29.77M vs. PHAT: $875.45M
KLTO [@Biotechnology] is valued at $29.77M. PHAT’s [@Biotechnology] market capitalization is $875.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KLTO’s FA Score shows that 1 FA rating(s) are green whilePHAT’s FA Score has 0 green FA rating(s).

  • KLTO’s FA Score: 1 green, 4 red.
  • PHAT’s FA Score: 0 green, 5 red.
According to our system of comparison, KLTO is a better buy in the long-term than PHAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KLTO’s TA Score shows that 3 TA indicator(s) are bullish while PHAT’s TA Score has 3 bullish TA indicator(s).

  • KLTO’s TA Score: 3 bullish, 4 bearish.
  • PHAT’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, KLTO is a better buy in the short-term than PHAT.

Price Growth

KLTO (@Biotechnology) experienced а -30.07% price change this week, while PHAT (@Biotechnology) price change was +1.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

PHAT is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PHAT($875M) has a higher market cap than KLTO($29.8M). PHAT YTD gains are higher at: 51.970 vs. KLTO (0.021). KLTO has higher annual earnings (EBITDA): -6.8M vs. PHAT (-256.76M). PHAT has more cash in the bank: 150M vs. KLTO (566K). KLTO has less debt than PHAT: KLTO (1.77M) vs PHAT (206M). PHAT has higher revenues than KLTO: PHAT (114M) vs KLTO (0).
KLTOPHATKLTO / PHAT
Capitalization29.8M875M3%
EBITDA-6.8M-256.76M3%
Gain YTD0.02151.9700%
P/E RatioN/AN/A-
Revenue0114M-
Total Cash566K150M0%
Total Debt1.77M206M1%
FUNDAMENTALS RATINGS
PHAT: Fundamental Ratings
PHAT
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KLTOPHAT
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
38%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 13 days ago
66%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
KLTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PHAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MABAX20.470.06
+0.29%
BlackRock Large Cap Focus Value Instl
BMRRX34.62N/A
N/A
BlackRock Mid-Cap Growth Equity R
MENYX9.59N/A
N/A
Madison Covered Call & Equity Income Y
NRECX13.79N/A
N/A
Neuberger Berman Real Estate C
TGPEX11.05N/A
N/A
T. Rowe Price Global Impact Equity Inv

KLTO and

Correlation & Price change

A.I.dvisor indicates that over the last year, KLTO has been loosely correlated with PHAT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if KLTO jumps, then PHAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KLTO
1D Price
Change %
KLTO100%
-2.00%
PHAT - KLTO
42%
Loosely correlated
+2.83%
CTXR - KLTO
36%
Loosely correlated
+6.96%
ANIX - KLTO
33%
Loosely correlated
N/A
TAOX - KLTO
29%
Poorly correlated
+6.91%
KALA - KLTO
27%
Poorly correlated
+0.14%
More

PHAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with KLTO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then KLTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
+2.83%
KLTO - PHAT
42%
Loosely correlated
-2.00%
RGNX - PHAT
36%
Loosely correlated
+3.08%
URGN - PHAT
35%
Loosely correlated
+0.43%
ACIU - PHAT
33%
Poorly correlated
+6.05%
PDSB - PHAT
32%
Poorly correlated
-1.64%
More